From Medscape Diabetes & Endocrinology

Medscape Medical News from the:

American Society for Bone and Mineral Research (ASBMR) 2012 Annual Meeting

October 12 - 15, 2012; Minneapolis, Minnesota

This coverage is not sanctioned by, nor a part of, the American Society for Bone and Mineral Research.

Conference News

ASBMR Adding Teriparatide Raises Hip BMD More Than Switching Drugs
Medscape Medical News, October 24, 2012
ASBMR FRAX Inferior to Other Tools in Osteoporosis Screening
Medscape Medical News, October 23, 2012
ASBMR Pediatric Bone Mass Tracks Partially Into Adulthood
Medscape Medical News, October 23, 2012
ASBMR Oral PTH Formulation Boosts BMD in Osteoporotic Women
Medscape Medical News, October 23, 2012
ASBMR Vitamin D Consensus Remains Elusive Despite Recommendations
Medscape Medical News, October 22, 2012
ASBMR Odanacatib Increases BMD After Alendronate Treatment
Medscape Medical News, October 19, 2012
ASBMR Combination Therapy Beats Monotherapy for Bone Density
Medscape Medical News, October 19, 2012
ASBMR Fracture Risk Increases After Antihypertensive Initiation
Medscape Medical News, October 17, 2012
ASBMR High-Resolution CT Details Estrogen's Effects on Bone
Medscape Medical News, October 17, 2012
ASBMR Bone Marrow Density Improved With New Drug, Romosozumab
Medscape Medical News, October 16, 2012

Medscape Diabetes© WebMD, LLC

Previous ASBMR Coverage

ASBMR 2011 Annual Meeting

ASBMR 2010 Annual Meeting

ASBMR 2009 Annual Meeting

All material on this website is protected by copyright, Copyright © 1994-2020 by WebMD LLC. This website also contains material copyrighted by 3rd parties.